Cargando…
Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
Thyroid gland presents a wide spectrum of tumours derived from follicular cells that range from well differentiated, papillary and follicular carcinoma (PTC and FTC, respectively), usually carrying a good prognosis, to the clinically aggressive, poorly differentiated (PDTC) and undifferentiated thyr...
Autores principales: | Soares, Paula, Lima, Jorge, Preto, Ana, Castro, Patricia, Vinagre, João, Celestino, Ricardo, Couto, Joana P, Prazeres, Hugo, Eloy, Catarina, Máximo, Valdemar, Sobrinho-Simões, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271313/ https://www.ncbi.nlm.nih.gov/pubmed/22654560 http://dx.doi.org/10.2174/138920211798120853 |
Ejemplares similares
-
TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
por: Melo, Miguel, et al.
Publicado: (2014) -
How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer
por: Prazeres, Hugo, et al.
Publicado: (2011) -
Corrigendum to “How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer”
por: Prazeres, Hugo, et al.
Publicado: (2016) -
Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review
por: Batista, Rui, et al.
Publicado: (2020) -
Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid
por: Máximo, Valdemar, et al.
Publicado: (2004)